{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:02:59Z","timestamp":1793458979515,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006510","name":"Association pour la Recherche sur la Scl\u00e9rose Lat\u00e9rale Amyotrophique et autres Maladies du Motoneurone","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Aide \u00e0 la Recherche des Maladies du Cerveau"},{"name":"Scl\u00e9rose Lat\u00e9rale Amyotrophique Fondation Recherche"},{"name":"Un pied devant l\u2019autre"},{"name":"Les invincibles all united"},{"name":"Fondation AP-HP"},{"name":"National Fili\u00e8re de Sant\u00e9 Maladies Rares SLA et Maladies du Neurone moteur"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00415-025-13007-1","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T11:29:25Z","timestamp":1742297365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["MAPT mutations in amyotrophic lateral sclerosis: clinical, neuropathological and functional insights"],"prefix":"10.1007","volume":"272","author":[{"given":"Sibylle","family":"De Bertier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Lautrette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-del-Mar","family":"Amador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Boill\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Stefan","family":"Lobsiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Bohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Darios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Machat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Duchesne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Vourc\u2019h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Fauret-Amsellem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Corcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Couratier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Seilhean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0745-6735","authenticated-orcid":false,"given":"St\u00e9phanie","family":"Millecamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"13007_CR1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","volume":"3","author":"M Goedert","year":"1989","unstructured":"Goedert M, Spillantini MG, Jakes R et al (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer\u2019s disease. Neuron 3:519\u2013526. https:\/\/doi.org\/10.1016\/0896-6273(89)90210-9","journal-title":"Neuron"},{"key":"13007_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-pathmechdis-051222-120750","volume":"19","author":"BC Creekmore","year":"2024","unstructured":"Creekmore BC, Watanabe R, Lee EB (2024) Neurodegenerative disease tauopathies. Annu Rev Pathol 19:345\u2013370. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-051222-120750","journal-title":"Annu Rev Pathol"},{"key":"13007_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12883-017-0966-3","volume":"17","author":"H-C Lin","year":"2017","unstructured":"Lin H-C, Lin C-H, Chen P-L et al (2017) Intrafamilial phenotypic heterogeneity in a Taiwanese family with a MAPT p.R5H mutation: a case report and literature review. BMC Neurol 17:186. https:\/\/doi.org\/10.1186\/s12883-017-0966-3","journal-title":"BMC Neurol"},{"key":"13007_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-014-1293-z","volume":"128","author":"M Popovi\u0107","year":"2014","unstructured":"Popovi\u0107 M, Fabjan A, Mraz J et al (2014) Tau protein mutation P364S in two sisters: clinical course and neuropathology with emphasis on new, composite neuronal tau inclusions. Acta Neuropathol 128:155\u2013157. https:\/\/doi.org\/10.1007\/s00401-014-1293-z","journal-title":"Acta Neuropathol"},{"key":"13007_CR5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/nan.12456","volume":"44","author":"P \u0160trafela","year":"2018","unstructured":"\u0160trafela P, Ple\u0161ko J, Magdi\u010d J et al (2018) Familial tauopathy with P364S MAPT mutation: clinical course, neuropathology and ultrastructure of neuronal tau inclusions. Neuropathol Appl Neurobiol 44:550\u2013562. https:\/\/doi.org\/10.1111\/nan.12456","journal-title":"Neuropathol Appl Neurobiol"},{"key":"13007_CR6","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1212\/01.WNL.0000160116.65034.12","volume":"64","author":"JJ Zarranz","year":"2005","unstructured":"Zarranz JJ, Ferrer I, Lezcano E et al (2005) A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Neurology 64:1578\u20131585. https:\/\/doi.org\/10.1212\/01.WNL.0000160116.65034.12","journal-title":"Neurology"},{"key":"13007_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1159\/000497820","volume":"18","author":"P Origone","year":"2018","unstructured":"Origone P, Geroldi A, Lamp M et al (2018) Role of MAPT in pure motor neuron disease: report of a recurrent mutation in Italian patients. Neurodegener Dis 18:310\u2013314. https:\/\/doi.org\/10.1159\/000497820","journal-title":"Neurodegener Dis"},{"key":"13007_CR8","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1212\/WNL.0000000000000476","volume":"82","author":"A Di Fonzo","year":"2014","unstructured":"Di Fonzo A, Ronchi D, Gallia F et al (2014) Lower motor neuron disease with respiratory failure caused by a novel MAPT mutation. Neurology 82:1990\u20131998. https:\/\/doi.org\/10.1212\/WNL.0000000000000476","journal-title":"Neurology"},{"key":"13007_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jns.2005.04.004","volume":"236","author":"C M\u00fcnch","year":"2005","unstructured":"M\u00fcnch C, Prechter F, Xu R et al (2005) Frequency of a tau genotype in amyotrophic lateral sclerosis. J Neurol Sci 236:13\u201316. https:\/\/doi.org\/10.1016\/j.jns.2005.04.004","journal-title":"J Neurol Sci"},{"key":"13007_CR10","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.3969\/j.issn.1673-5374.2013.33.005","volume":"8","author":"P Fang","year":"2013","unstructured":"Fang P, Xu W, Wu C et al (2013) MAPT as a predisposing gene for sporadic amyotrophic lateral sclerosis in the Chinese Han population. Neural Regen Res 8:3116\u20133123. https:\/\/doi.org\/10.3969\/j.issn.1673-5374.2013.33.005","journal-title":"Neural Regen Res"},{"key":"13007_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13035","author":"T Petrozziello","year":"2022","unstructured":"Petrozziello T, Amaral AC, Dujardin S et al (2022) Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post-mortem motor cortex and cerebrospinal fluid. Brain Pathol. https:\/\/doi.org\/10.1111\/bpa.13035","journal-title":"Brain Pathol"},{"key":"13007_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks BR, Miller RG, Swash M et al (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293\u2013299. https:\/\/doi.org\/10.1080\/146608200300079536","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"13007_CR13","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134:2456\u20132477. https:\/\/doi.org\/10.1093\/brain\/awr179","journal-title":"Brain"},{"key":"13007_CR14","doi-asserted-by":"publisher","first-page":"102.e11","DOI":"10.1016\/j.neurobiolaging.2020.10.015","volume":"99","author":"E Teyssou","year":"2021","unstructured":"Teyssou E, Muratet F, Amador M-D-M et al (2021) Genetic screening of ANXA11 revealed novel mutations linked to amyotrophic lateral sclerosis. Neurobiol Aging 99:102.e11-102.e20. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.10.015","journal-title":"Neurobiol Aging"},{"key":"13007_CR15","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V et al (2016) REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet 99:877\u2013885. https:\/\/doi.org\/10.1016\/j.ajhg.2016.08.016","journal-title":"Am J Hum Genet"},{"key":"13007_CR16","doi-asserted-by":"publisher","first-page":"10881","DOI":"10.1093\/nar\/16.22.10881","volume":"16","author":"F Corpet","year":"1988","unstructured":"Corpet F (1988) Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res 16:10881\u201310890. https:\/\/doi.org\/10.1093\/nar\/16.22.10881","journal-title":"Nucleic Acids Res"},{"key":"13007_CR17","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nprot.2015.053","volume":"10","author":"LA Kelley","year":"2015","unstructured":"Kelley LA, Mezulis S, Yates CM et al (2015) The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc 10:845\u2013858. https:\/\/doi.org\/10.1038\/nprot.2015.053","journal-title":"Nat Protoc"},{"key":"13007_CR18","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1016\/j.jmb.2018.01.013","volume":"430","author":"CR Reynolds","year":"2018","unstructured":"Reynolds CR, Islam SA, Sternberg MJE (2018) EzMol: a web server wizard for the rapid visualization and image production of protein and nucleic acid structures. J Mol Biol 430:2244\u20132248. https:\/\/doi.org\/10.1016\/j.jmb.2018.01.013","journal-title":"J Mol Biol"},{"key":"13007_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.2848","volume":"33","author":"E Moreno-Castillo","year":"2020","unstructured":"Moreno-Castillo E, \u00c1lvarez-Ginarte YM, Vald\u00e9s-Tresanco ME et al (2020) Understanding the disrupting mechanism of the Tau aggregation motif \u201c306VQIVYK311\u201d by phenylthiazolyl-hydrazides inhibitors. J Mol Recognit 33:e2848. https:\/\/doi.org\/10.1002\/jmr.2848","journal-title":"J Mol Recognit"},{"key":"13007_CR20","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/31508","volume":"393","author":"M Hutton","year":"1998","unstructured":"Hutton M, Lendon CL, Rizzu P et al (1998) Association of missense and 5\u2019-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702\u2013705. https:\/\/doi.org\/10.1038\/31508","journal-title":"Nature"},{"key":"13007_CR21","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/00005072-199906000-00011","volume":"58","author":"O Bugiani","year":"1999","unstructured":"Bugiani O, Murrell JR, Giaccone G et al (1999) Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in Tau. J Neuropathol Exp Neurol 58:667\u2013677. https:\/\/doi.org\/10.1097\/00005072-199906000-00011","journal-title":"J Neuropathol Exp Neurol"},{"key":"13007_CR22","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/21678421.2019.1606244","volume":"20","author":"RAA van der Spek","year":"2019","unstructured":"van der Spek RAA, van Rheenen W, Pulit SL et al (2019) The project MinE databrowser: bringing large-scale whole-genome sequencing in ALS to researchers and the public. Amyotroph Lateral Scler Frontotemporal Degener 20:432\u2013440. https:\/\/doi.org\/10.1080\/21678421.2019.1606244","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"13007_CR23","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch P, Witten D, Cooper GM et al (2019) CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res 47:D886\u2013D894. https:\/\/doi.org\/10.1093\/nar\/gky1016","journal-title":"Nucleic Acids Res"},{"key":"13007_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"13007_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177914","volume":"12","author":"SB Nicholls","year":"2017","unstructured":"Nicholls SB, DeVos SL, Commins C et al (2017) Characterization of TauC3 antibody and demonstration of its potential to block tau propagation. PLoS ONE 12:e0177914. https:\/\/doi.org\/10.1371\/journal.pone.0177914","journal-title":"PLoS ONE"},{"key":"13007_CR26","doi-asserted-by":"publisher","first-page":"834.e1","DOI":"10.1016\/j.neurobiolaging.2011.08.008","volume":"33","author":"G Rossi","year":"2012","unstructured":"Rossi G, Bastone A, Piccoli E et al (2012) New mutations in MAPT gene causing frontotemporal lobar degeneration: biochemical and structural characterization. Neurobiol Aging 33:834.e1-834.e6. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.08.008","journal-title":"Neurobiol Aging"},{"key":"13007_CR27","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/s41591-024-02937-4","volume":"30","author":"M Chatterjee","year":"2024","unstructured":"Chatterjee M, \u00d6zdemir S, Fritz C et al (2024) Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS. Nat Med 30:1771\u20131783. https:\/\/doi.org\/10.1038\/s41591-024-02937-4","journal-title":"Nat Med"},{"key":"13007_CR28","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/mdc3.14042","volume":"11","author":"H Morino","year":"2024","unstructured":"Morino H, Kurashige T, Matsuda Y et al (2024) Clinical and pathological features of FTDP-17 with MAPT p. K298_H299insQ mutation. Mov Disord Clin Pract 11:720\u2013727. https:\/\/doi.org\/10.1002\/mdc3.14042","journal-title":"Mov Disord Clin Pract"},{"key":"13007_CR29","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.neurol.2021.01.008","volume":"177","author":"M-D-M Amador","year":"2021","unstructured":"Amador M-D-M, Muratet F, Teyssou E et al (2021) New advances in amyotrophic lateral sclerosis genetics: towards gene therapy opportunities for familial and young cases. Rev Neurol (Paris) 177:524\u2013535. https:\/\/doi.org\/10.1016\/j.neurol.2021.01.008","journal-title":"Rev Neurol (Paris)"},{"key":"13007_CR30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/humu.23161","volume":"38","author":"J van der Zee","year":"2017","unstructured":"van der Zee J, Gijselinck I, Van Mossevelde S et al (2017) TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis. Hum Mutat 38:297\u2013309. https:\/\/doi.org\/10.1002\/humu.23161","journal-title":"Hum Mutat"},{"key":"13007_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1474-4422(19)30394-1","volume":"19","author":"KM Moore","year":"2020","unstructured":"Moore KM, Nicholas J, Grossman M et al (2020) Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. Lancet Neurol 19:145\u2013156. https:\/\/doi.org\/10.1016\/S1474-4422(19)30394-1","journal-title":"Lancet Neurol"},{"key":"13007_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00401-003-0734-x","volume":"106","author":"M Hogg","year":"2003","unstructured":"Hogg M, Grujic ZM, Baker M et al (2003) The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy. Acta Neuropathol 106:323\u2013336. https:\/\/doi.org\/10.1007\/s00401-003-0734-x","journal-title":"Acta Neuropathol"},{"key":"13007_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/ana.10447","volume":"53","author":"T Kobayashi","year":"2003","unstructured":"Kobayashi T, Ota S, Tanaka K et al (2003) A novel L266V mutation of the tau gene causes frontotemporal dementia with a unique tau pathology. Ann Neurol 53:133\u2013137. https:\/\/doi.org\/10.1002\/ana.10447","journal-title":"Ann Neurol"},{"key":"13007_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-013-1193-7","author":"N Kouri","year":"2013","unstructured":"Kouri N, Carlomagno Y, Baker M et al (2013) Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-013-1193-7","journal-title":"Acta Neuropathol"},{"key":"13007_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031039","volume":"7","author":"C Cruchaga","year":"2012","unstructured":"Cruchaga C, Chakraverty S, Mayo K et al (2012) Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer\u2019s disease families. PLoS ONE 7:e31039. https:\/\/doi.org\/10.1371\/journal.pone.0031039","journal-title":"PLoS ONE"},{"key":"13007_CR36","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1073\/pnas.97.10.5129","volume":"97","author":"M von Bergen","year":"2000","unstructured":"von Bergen M, Friedhoff P, Biernat J et al (2000) Assembly of \u03c4 protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming \u03b2 structure. Proc Natl Acad Sci 97:5129\u20135134. https:\/\/doi.org\/10.1073\/pnas.97.10.5129","journal-title":"Proc Natl Acad Sci"},{"key":"13007_CR37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/jb\/mvs061","volume":"152","author":"K Sogawa","year":"2012","unstructured":"Sogawa K, Okuda R, In Y et al (2012) C-H \u2026 \u03c0 interplay between Ile308 and Tyr310 residues in the third repeat of microtubule binding domain is indispensable for self-assembly of three- and four-repeat tau. J Biochem 152:221\u2013229. https:\/\/doi.org\/10.1093\/jb\/mvs061","journal-title":"J Biochem"},{"key":"13007_CR38","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1016\/j.febslet.2010.09.012","volume":"584","author":"K Naruto","year":"2010","unstructured":"Naruto K, Minoura K, Okuda R et al (2010) Interplay between I308 and Y310 residues in the third repeat of microtubule-binding domain is essential for tau filament formation. FEBS Lett 584:4233\u20134236. https:\/\/doi.org\/10.1016\/j.febslet.2010.09.012","journal-title":"FEBS Lett"},{"key":"13007_CR39","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/bip.22489","volume":"102","author":"K Sogawa","year":"2014","unstructured":"Sogawa K, Minoura K, In Y et al (2014) CH-\u03c0 interaction in VQIVYK sequence elucidated by NMR spectroscopy is essential for PHF formation of tau. Biopolymers 102:288\u2013295. https:\/\/doi.org\/10.1002\/bip.22489","journal-title":"Biopolymers"},{"key":"13007_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00488","author":"AS Cieplak","year":"2019","unstructured":"Cieplak AS (2019) Tau inclusions in Alzheimer\u2019s chronic traumatic encephalopathy and Pick\u2019s disease. A speculation on how differences in backbone polarization underlie divergent pathways of Tau aggregation. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2019.00488","journal-title":"Front Neurosci"},{"key":"13007_CR41","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/BF00294807","volume":"90","author":"N Murakami","year":"1995","unstructured":"Murakami N, Ishiguro K, Ihara Y et al (1995) Tau protein immunoreactivity in muscle fibers with rimmed vacuoles differs from that in regenerating muscle fibers. Acta Neuropathol 90:467\u2013471. https:\/\/doi.org\/10.1007\/BF00294807","journal-title":"Acta Neuropathol"},{"key":"13007_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-006-0079-3","author":"A Fidzia\u0144ska","year":"2006","unstructured":"Fidzia\u0144ska A, Glinka Z (2006) Rimmed vacuoles with beta-amyloid and tau protein deposits in the muscle of children with hereditary myopathy. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-006-0079-3","journal-title":"Acta Neuropathol"},{"key":"13007_CR43","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/jnc.12991","volume":"133","author":"S Sokolow","year":"2015","unstructured":"Sokolow S, Henkins KM, Bilousova T et al (2015) Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer\u2019s disease. J Neurochem 133:368\u2013379. https:\/\/doi.org\/10.1111\/jnc.12991","journal-title":"J Neurochem"},{"key":"13007_CR44","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1007\/s12035-023-03434-4","volume":"60","author":"MA Olesen","year":"2023","unstructured":"Olesen MA, Quintanilla RA (2023) Pathological impact of tau proteolytical process on neuronal and mitochondrial function: a crucial role in Alzheimer\u2019s disease. Mol Neurobiol 60:5691\u20135707. https:\/\/doi.org\/10.1007\/s12035-023-03434-4","journal-title":"Mol Neurobiol"},{"key":"13007_CR45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fncel.2020.00175","volume":"14","author":"RA Quintanilla","year":"2020","unstructured":"Quintanilla RA, Tapia-Monsalves C, Vergara EH et al (2020) Truncated tau induces mitochondrial transport failure through the impairment of TRAK2 protein and bioenergetics decline in neuronal cells. Front Cell Neurosci 14:175. https:\/\/doi.org\/10.3389\/fncel.2020.00175","journal-title":"Front Cell Neurosci"},{"key":"13007_CR46","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1038\/s41380-022-01538-2","volume":"27","author":"C Conze","year":"2022","unstructured":"Conze C, Rierola M, Trushina NI et al (2022) Caspase-cleaved tau is senescence-associated and induces a toxic gain of function by putting a brake on axonal transport. Mol Psychiatry 27:3010\u20133023. https:\/\/doi.org\/10.1038\/s41380-022-01538-2","journal-title":"Mol Psychiatry"},{"key":"13007_CR47","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1093\/brain\/awv222","volume":"138","author":"M Iovino","year":"2015","unstructured":"Iovino M, Agathou S, Gonz\u00e1lez-Rueda A et al (2015) Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations. Brain 138:3345\u20133359. https:\/\/doi.org\/10.1093\/brain\/awv222","journal-title":"Brain"},{"key":"13007_CR48","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.021766","author":"C-C Xu","year":"2015","unstructured":"Xu C-C, Denton KR, Wang Z-B et al (2015) Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy. Dis Models Mech. https:\/\/doi.org\/10.1242\/dmm.021766","journal-title":"Dis Models Mech"},{"key":"13007_CR49","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1093\/hmg\/ddl431","volume":"15","author":"A Tarrade","year":"2006","unstructured":"Tarrade A, Fassier C, Courageot S et al (2006) A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition. Hum Mol Genet 15:3544\u20133558. https:\/\/doi.org\/10.1093\/hmg\/ddl431","journal-title":"Hum Mol Genet"},{"key":"13007_CR50","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/stem.1569","volume":"32","author":"KR Denton","year":"2014","unstructured":"Denton KR, Lei L, Grenier J et al (2014) Loss of spastin function results in disease-specific axonal defects in human pluripotent stem cell-based models of hereditary spastic paraplegia. Stem Cells 32:414\u2013423. https:\/\/doi.org\/10.1002\/stem.1569","journal-title":"Stem Cells"},{"key":"13007_CR51","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1093\/hmg\/ddm226","volume":"16","author":"KJ De Vos","year":"2007","unstructured":"De Vos KJ, Chapman AL, Tennant ME et al (2007) Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum Mol Genet 16:2720\u20132728. https:\/\/doi.org\/10.1093\/hmg\/ddm226","journal-title":"Hum Mol Genet"},{"key":"13007_CR52","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1093\/hmg\/ddp421","volume":"18","author":"J Magran\u00e9","year":"2009","unstructured":"Magran\u00e9 J, Hervias I, Henning MS et al (2009) Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities. Hum Mol Genet 18:4552\u20134564. https:\/\/doi.org\/10.1093\/hmg\/ddp421","journal-title":"Hum Mol Genet"},{"key":"13007_CR53","doi-asserted-by":"publisher","first-page":"e106177","DOI":"10.15252\/embj.2020106177","volume":"40","author":"R Fazal","year":"2021","unstructured":"Fazal R, Boeynaems S, Swijsen A et al (2021) HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutations. EMBO J 40:e106177. https:\/\/doi.org\/10.15252\/embj.2020106177","journal-title":"EMBO J"},{"key":"13007_CR54","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41467-017-00911-y","volume":"8","author":"W Guo","year":"2017","unstructured":"Guo W, Naujock M, Fumagalli L et al (2017) HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat Commun 8:861. https:\/\/doi.org\/10.1038\/s41467-017-00911-y","journal-title":"Nat Commun"},{"key":"13007_CR55","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/aja.1001940306","volume":"194","author":"NR Cashman","year":"1992","unstructured":"Cashman NR, Durham HD, Blusztajn JK et al (1992) Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn 194:209\u2013221. https:\/\/doi.org\/10.1002\/aja.1001940306","journal-title":"Dev Dyn"},{"key":"13007_CR56","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1046\/j.1471-4159.2000.0741895.x","volume":"74","author":"CJ Eggett","year":"2000","unstructured":"Eggett CJ, Crosier S, Manning P et al (2000) Development and characterisation of a glutamate-sensitive motor neurone cell line. J Neurochem 74:1895\u20131902. https:\/\/doi.org\/10.1046\/j.1471-4159.2000.0741895.x","journal-title":"J Neurochem"},{"key":"13007_CR57","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.neuint.2013.03.008","volume":"62","author":"O Maier","year":"2013","unstructured":"Maier O, B\u00f6hm J, Dahm M et al (2013) Differentiated NSC-34 motoneuron-like cells as experimental model for cholinergic neurodegeneration. Neurochem Int 62:1029\u20131038. https:\/\/doi.org\/10.1016\/j.neuint.2013.03.008","journal-title":"Neurochem Int"},{"key":"13007_CR58","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.omtn.2022.07.027","volume":"29","author":"A Easton","year":"2022","unstructured":"Easton A, Jensen ML, Wang C et al (2022) Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies. Mol Ther Nucleic Acids 29:625\u2013642. https:\/\/doi.org\/10.1016\/j.omtn.2022.07.027","journal-title":"Mol Ther Nucleic Acids"},{"key":"13007_CR59","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/s41591-023-02326-3","volume":"29","author":"CJ Mummery","year":"2023","unstructured":"Mummery CJ, B\u00f6rjesson-Hanson A, Blackburn DJ et al (2023) Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer\u2019s disease: a phase 1b, randomized, placebo-controlled trial. Nat Med 29:1437\u20131447. https:\/\/doi.org\/10.1038\/s41591-023-02326-3","journal-title":"Nat Med"},{"key":"13007_CR60","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/brain\/awae254","volume":"148","author":"E Cruz","year":"2025","unstructured":"Cruz E, Nisbet RM, Padmanabhan P et al (2025) Proteostasis as a fundamental principle of Tau immunotherapy. Brain 148:168\u2013184. https:\/\/doi.org\/10.1093\/brain\/awae254","journal-title":"Brain"},{"key":"13007_CR61","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S1474-4422(20)30489-0","volume":"20","author":"GU H\u00f6glinger","year":"2021","unstructured":"H\u00f6glinger GU, Litvan I, Mendonca N et al (2021) Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial. Lancet Neurol 20:182\u2013192. https:\/\/doi.org\/10.1016\/S1474-4422(20)30489-0","journal-title":"Lancet Neurol"},{"key":"13007_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105120","volume":"146","author":"R Sopko","year":"2020","unstructured":"Sopko R, Golonzhka O, Arndt J et al (2020) Characterization of tau binding by gosuranemab. Neurobiol Dis 146:105120. https:\/\/doi.org\/10.1016\/j.nbd.2020.105120","journal-title":"Neurobiol Dis"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13007-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13007-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13007-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T10:09:59Z","timestamp":1744970999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13007-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["13007"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13007-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests relevant to the content of this article to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"272"}}